$ENDI
ENDI Corp.

2023 Q2 Form 10-Q Financial Statement

#000149315223027817 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4 2022 Q2
Revenue $2.297M $1.762M
YoY Change 30.35%
Cost Of Revenue $55.02K $111.8K
YoY Change -50.8% -63.49%
Gross Profit $2.242M $141.9K
YoY Change 1480.22% -92.16%
Gross Profit Margin 97.6% 8.05%
Selling, General & Admin $674.4K
YoY Change 59.49%
% of Gross Profit 475.3%
Research & Development $45.13K $50.69K
YoY Change -10.97%
% of Gross Profit 2.01% 35.72%
Depreciation & Amortization $1.011K
YoY Change 0.0%
% of Gross Profit 0.71%
Operating Expenses $1.798M $674.4K
YoY Change 166.56% 59.49%
Operating Profit $444.5K -$532.5K
YoY Change -183.47% -138.41%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $617.2K $32.19K
YoY Change 1817.55% -95.8%
Pretax Income -$500.3K
YoY Change -123.25%
Income Tax $208.9K $0.00
% Of Pretax Income
Net Earnings $852.9K $538.3K -$500.3K
YoY Change -270.46% -9.72% -123.25%
Net Earnings / Revenue 37.13% -28.39%
Basic Earnings Per Share $0.16 -$0.19
Diluted Earnings Per Share $0.16 -$0.19
COMMON SHARES
Basic Shares Outstanding 1.800M 2.647M
Diluted Shares Outstanding 5.468M shares 2.647M

Balance Sheet

Concept 2023 Q2 2022 Q4 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $9.338M $10.69M $16.01M
Short-Term Investments
Other Short-Term Assets $57.45K $11.85K
YoY Change 795.22%
Inventory
Prepaid Expenses $122.4K $91.47K
Receivables $916.5K $744.6K $39.66K
Other Receivables $123.8K
Total Short-Term Assets $18.18M $17.62M $16.08M
YoY Change 13.04% 0.22%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $7.639K
YoY Change -100.0%
Goodwill $737.9K $737.9K $212.4K
YoY Change 247.32% 247.32% 0.0%
Intangibles $3.461M $1.224M
YoY Change
Long-Term Investments
YoY Change
Other Assets $58.13K
YoY Change
Total Long-Term Assets $7.134M $3.853M $328.2K
YoY Change 2073.49% 967.35%
TOTAL ASSETS
Total Short-Term Assets $18.18M $17.62M $16.08M
Total Long-Term Assets $7.134M $3.853M $328.2K
Total Assets $25.31M $21.47M $16.41M
YoY Change 54.26% 19.68% -12.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $28.30K $71.31K $11.09K
YoY Change 155.07% 521.46%
Accrued Expenses $172.9K $260.2K $332.4K
YoY Change -47.99% -15.54%
Deferred Revenue $167.5K $156.9K $190.8K
YoY Change -12.21% -8.37%
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.164M $512.8K $534.3K
YoY Change 305.01% -38.59%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.782M $576.0K
YoY Change -82.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.164M $512.8K $534.3K
Total Long-Term Liabilities $1.782M $576.0K
Total Liabilities $3.946M $1.089M $534.3K
YoY Change 638.56% 30.4%
SHAREHOLDERS EQUITY
Retained Earnings $1.024M $164.7K -$12.13M
YoY Change -108.44% -101.51%
Common Stock $20.34M $20.22M $28.00M
YoY Change -27.37% -27.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.36M $20.38M $15.87M
YoY Change
Total Liabilities & Shareholders Equity $25.31M $21.47M $16.41M
YoY Change 54.26% 19.68%

Cashflow Statement

Concept 2023 Q2 2022 Q4 2022 Q2
OPERATING ACTIVITIES
Net Income $852.9K $538.3K -$500.3K
YoY Change -270.46% -9.72% -123.25%
Depreciation, Depletion And Amortization $1.011K
YoY Change 0.0%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001908984
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2022Q4 ENDI Investment In Limited Partnership At Net Asset Value
InvestmentInLimitedPartnershipAtNetAssetValue
usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
usd
CY2022Q2 ENDI Gain Loss On Periodic Revaluation Of Liability
GainLossOnPeriodicRevaluationOfLiability
usd
ENDI Gain Loss On Periodic Revaluation Of Liability
GainLossOnPeriodicRevaluationOfLiability
usd
CY2023Q2 ENDI Realized Gain On Note Receivable
RealizedGainOnNoteReceivable
usd
CY2022Q2 ENDI Realized Gain On Note Receivable
RealizedGainOnNoteReceivable
usd
ENDI Realized Gain On Note Receivable
RealizedGainOnNoteReceivable
usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
ENDI Realized Gain Loss On Notes Receivable
RealizedGainLossOnNotesReceivable
usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
usd
ENDI Payments To Acquire Strategic Income Fund Assets
PaymentsToAcquireStrategicIncomeFundAssets
usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
ENDI Payments Of Earnouts
PaymentsOfEarnouts
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
usd
CY2023Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
usd
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
usd
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
usd
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56469
dei Entity Registrant Name
EntityRegistrantName
ENDI CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-4284605
dei Entity Address Address Line1
EntityAddressAddressLine1
2400 Old Brick Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 115
dei Entity Address City Or Town
EntityAddressCityOrTown
Glen Allen
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23060
dei City Area Code
CityAreaCode
(434)
dei Local Phone Number
LocalPhoneNumber
336-7737
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9338304 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10690398 usd
CY2023Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
7798616 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
5860688 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
916453 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
744638 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
122441 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
91473 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
50000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
123823 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
57446 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
18175814 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
17618466 usd
CY2023Q2 us-gaap Goodwill
Goodwill
737869 usd
CY2022Q4 us-gaap Goodwill
Goodwill
737869 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3461054 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1223926 usd
CY2023Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1405266 usd
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
450000 usd
CY2023Q2 ENDI Investment In Limited Partnership At Net Asset Value
InvestmentInLimitedPartnershipAtNetAssetValue
194874 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1334532 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1441234 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
7133595 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3853029 usd
CY2023Q2 us-gaap Assets
Assets
25309409 usd
CY2022Q4 us-gaap Assets
Assets
21471495 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
28295 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
71306 usd
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
890750 usd
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
23342 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
172904 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
260185 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
167500 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
156859 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
117037 usd
CY2023Q2 ENDI Earnout Liability Current
EarnoutLiabilityCurrent
787007 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
674 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1110 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2164167 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
512802 usd
CY2023Q2 ENDI Earnout Liability Net Of Current Portion
EarnoutLiabilityNetOfCurrentPortion
1309263 usd
CY2023Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
473000 usd
CY2022Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
576000 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1782263 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
576000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
3946430 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1088802 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
545 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
545 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20338918 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20217472 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1023516 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
164676 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
21362979 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20382693 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25309409 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21471495 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2297285 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1762357 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4235214 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3469481 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
55021 usd
us-gaap Cost Of Revenue
CostOfRevenue
115773 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2242264 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
1762357 usd
us-gaap Gross Profit
GrossProfit
4119441 usd
us-gaap Gross Profit
GrossProfit
3469481 usd
CY2023Q2 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
1253504 usd
CY2022Q2 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
787834 usd
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
2403234 usd
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
1544477 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39700 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
121446 usd
CY2023Q2 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
45126 usd
CY2022Q2 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
50689 usd
us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
91895 usd
us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
79567 usd
CY2023Q2 ENDI Mutual Fund Expenses
MutualFundExpenses
126879 usd
CY2022Q2 ENDI Mutual Fund Expenses
MutualFundExpenses
68119 usd
ENDI Mutual Fund Expenses
MutualFundExpenses
192152 usd
ENDI Mutual Fund Expenses
MutualFundExpenses
116091 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
12706 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
25819 usd
us-gaap Professional Fees
ProfessionalFees
570699 usd
us-gaap Professional Fees
ProfessionalFees
27019 usd
CY2023Q2 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
83775 usd
CY2022Q2 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
39907 usd
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
174524 usd
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
51985 usd
CY2023Q2 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
236064 usd
CY2022Q2 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
13429 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
403020 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
109323 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1797754 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
985797 usd
us-gaap Operating Expenses
OperatingExpenses
3956970 usd
us-gaap Operating Expenses
OperatingExpenses
1928462 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
444510 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
776560 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
162471 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1541019 usd
CY2023Q2 ENDI Gain Loss On Periodic Revaluation Of Liability
GainLossOnPeriodicRevaluationOfLiability
-355000 usd
ENDI Gain Loss On Periodic Revaluation Of Liability
GainLossOnPeriodicRevaluationOfLiability
-103000 usd
ENDI Realized Gain On Note Receivable
RealizedGainOnNoteReceivable
334400 usd
CY2023Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
97849 usd
CY2022Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
14758 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
209963 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
24557 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
161377 usd
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-28433 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
269524 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-41074 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3015 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20592 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
617241 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13675 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
937479 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16517 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
208877 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
241110 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
852874 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
762885 usd
us-gaap Net Income Loss
NetIncomeLoss
858840 usd
us-gaap Net Income Loss
NetIncomeLoss
1524502 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5468133 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5468133 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2400000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5463086 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5463086 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2400000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20382693 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5966 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81746 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
20470405 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
852874 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39700 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
21362979 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
21362979 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
591909 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
761617 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1353526 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
762885 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2116411 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2116411 usd
us-gaap Net Income Loss
NetIncomeLoss
858840 usd
us-gaap Net Income Loss
NetIncomeLoss
1524502 usd
ENDI Realized Gain Loss On Notes Receivable
RealizedGainLossOnNotesReceivable
334400 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-103000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
121446 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
106702 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
104472 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
171815 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4655 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
30968 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-57446 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
6849 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-43011 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
867408 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
763750 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-87281 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-75798 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
10641 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
117037 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-436 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1473081 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2210260 usd
us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
1960290 usd
us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
-16532 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
955266 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
384400 usd
ENDI Payments To Acquire Strategic Income Fund Assets
PaymentsToAcquireStrategicIncomeFundAssets
199988 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
172512 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2903656 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16532 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
123823 usd
ENDI Payments Of Earnouts
PaymentsOfEarnouts
45342 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2437341 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
78481 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2437341 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1352094 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-210549 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10690398 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1272924 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9338304 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1062375 usd
CY2023Q2 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
194874 usd
us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
1200000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zRe9H8h36cGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zxwpmn7eyGAd">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with GAAP the preparation of these condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On an ongoing basis, management evaluates its estimates and judgments, including, among other items, those related to fair value of investments, revenue recognition, accrued expenses, financing operations, fair value of goodwill, fixed asset lives and impairment, lease right-of-use assets and impairment, deferred tax assets, liabilities and valuation allowance, other assets, the present value of lease liabilities, and contingencies and litigation. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions and conditions. These accounting policies are described at relevant sections in the notes to the unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zXTPmCmbj3R8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zqf7qmmFPrma">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash, cash equivalents, accounts receivable, and notes receivable. The Company places its cash with high-quality financial institutions and, at times, exceeds the FDIC and CDIC insurance limit. The Company extends credit based on an evaluation of customers’ financial condition, generally without collateral. Exposure to losses on receivables is principally dependent on each customer’s financial condition. The Company monitors its exposure for credit losses and maintains allowances for anticipated losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2203 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2283 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-924 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
320 usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3461054 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1223926 usd
CY2023Q2 ENDI Number Of Domain Names Owned
NumberOfDomainNamesOwned
242 integer
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
198277 shares
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39700 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
121446 usd
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1334532 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
208877 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
241110 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
15750 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
15750 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2050000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
15873598 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
35027 usd
CY2022Q3 ENDI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Note Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsNoteReceivables
50000 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
51933 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
119785 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
3431 usd
CY2022Q3 us-gaap Goodwill
Goodwill
737869 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
1255000 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
1249556 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
20506 usd
CY2022Q3 ENDI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
513922 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
203547 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
648 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
18637576 usd
CY2022Q3 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
300000 usd
CY2022Q4 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
50000 usd
CY2022Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1249556 usd
CY2022 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
939556 usd
CY2022Q3 us-gaap Goodwill Fair Value Disclosure
GoodwillFairValueDisclosure
1677425 usd
CY2022Q4 us-gaap Goodwill Fair Value Disclosure
GoodwillFairValueDisclosure
737869 usd
CY2022Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2016074 usd
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
3980173 usd
CY2022Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
243750 usd
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
253753 usd
CY2022Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.04
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.05
CY2023Q2 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
6960663 usd
CY2023Q2 ENDI Investment In Limited Partnership At Net Asset Value
InvestmentInLimitedPartnershipAtNetAssetValue
194874 usd
CY2023Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
194874 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
5802395 usd
CY2023Q2 us-gaap Investments
Investments
194874 usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
22362 usd
us-gaap Investment Income Net
InvestmentIncomeNet
22362 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3596600 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1255000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-135546 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-31074 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3461054 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1223926 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
83757 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
104472 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
14008 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
37922 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
26361 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
46156 usd
CY2023Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
17800000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares

Files In Submission

Name View Source Status
0001493152-23-027817-index-headers.html Edgar Link pending
0001493152-23-027817-index.html Edgar Link pending
0001493152-23-027817.txt Edgar Link pending
0001493152-23-027817-xbrl.zip Edgar Link pending
endi-20230630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
endi-20230630_lab.xml Edgar Link unprocessable
endi-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
endi-20230630_def.xml Edgar Link unprocessable
endi-20230630_cal.xml Edgar Link unprocessable